FDA approves standalone use of J&J’s ketamine-derived depression treatment
The U.S. Food and Drug Administration expanded approval for Johnson & Johnson’s nasal spray, Spravato, to allow it to be used ...
Hosted on MSN1h
FDA Clears Spravato For Monotherapy Depression Treatments
The Food and Drug Administration has approved Johnson & Johnson's nasal spray as a standalone treatment for severe forms of ...
Psychology Today21h
Treatment of Addiction
Whatever form it takes, successful treatment reverses the changes in brain circuitry that make substance use hard to control. Yet many factors other than biology must be addressed for treatment to ...
BMJ21h
EPILEPSY IN TOURETTE SYNDROME
Objective Tourette Syndrome (TS) is a neurodevelopmental disorder frequently ... clinical descriptions and treatment. Cases where epilepsy had been inappropriately suspected or misdiagnosed were ...